淋巴瘤病史患者新发肺结节一例
一例70岁女性既往吸烟者,在血液科随访中偶然发现肺结节。患者有IV期滤泡性淋巴瘤病史,接受6疗程奥妥珠单抗联合苯达莫司汀治疗,期间出现人疱疹病毒6型感染(病毒载量>13,000 copies/mL)并经阿昔洛韦治愈,完成治疗后达完全代谢缓解。治疗结束后1个月发生系统性巨细胞病毒感染伴肺炎,住院3周,因感染严重未行奥妥珠单抗维持治疗,持续CMV-DNA阳性需缬更昔洛韦,中性粒细胞减少经粒细胞集落刺激因子部分改善。
要点
- 免疫抑制治疗后的淋巴瘤患者出现新发肺结节需鉴别感染与肿瘤。
- 本例有HHV-6和CMV感染史,提示机会性感染风险。
- 肺结节评估需结合病史、影像与必要的有创检查。
核心结论
- 淋巴瘤病史及免疫抑制治疗后的患者新发肺结节,需综合鉴别感染、淋巴瘤累及及第二原发肿瘤。
研究设计与样本
- 单例病例报告:70岁女性,既往吸烟,IV期滤泡性淋巴瘤(G2/G3A,FLIPI4),接受6疗程奥妥珠单抗联合苯达莫司汀治疗。
主要发现
- 治疗第2周期后出现转氨酶升高,实时PCR血检HHV-6 DNA>13,000 copies/mL,经阿昔洛韦治疗后肝酶正常化。
- 完成治疗获完全代谢缓解;治疗结束后1个月发生系统性CMV感染伴肺炎,住院3周。
- 因感染严重未行奥妥珠单抗维持;持续CMV-DNA阳性需缬更昔洛韦;中性粒细胞减少经G-CSF部分改善。
临床怎么用
- 对免疫抑制后患者的新发肺结节,应同时评估感染性与肿瘤性病因。
局限性
- 单例病例报告,结论不能推广至其他患者。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
A 70-year-old woman who formerly used tobacco was referred for evaluation of a lung nodule incidentally discovered during hematologic follow-up. Her medical history was notable for a stage IV follicular lymphoma (G2/G3A stage IV, for pleural and perinephric involvement, FLIPI4) in September 2022, for which she received 6 courses of obinutuzumab plus bendamustine. After the second cycle of therapy, an increase in transaminases was detected; the subsequent diagnostic workup showed a positive real-time polymerase chain reaction blood test for human herpesvirus 6 DNA with more than 13,000 copies/mL. The human herpesvirus 6 infection was successfully treated with acyclovir, followed by normalization of liver enzymes. The treatment was then completed regularly, obtaining a complete metabolic response. One month after completing therapy, the patient developed systemic cytomegalovirus infection with associated pneumonia, requiring 3 weeks of hospitalization. Considering the severity of the infectious event, a further maintenance with obinutuzumab was excluded. Persistent cytomegalovirus-DNA levels necessitated valganciclovir. Sustained neutropenia partially improved with granulocyte colony-stimulating factor administration.
引用
- Vilaia A, Pezzuto F, Scapinello G, et al. A New Pulmonary Nodule in a Patient With a History of Lymphoma. Chest. 2025. PMID: 40210319. doi:10.1016/j.chest.2024.11.024
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。